1. Home
  2. BFRG vs BNGO Comparison

BFRG vs BNGO Comparison

Compare BFRG & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFRG

Bullfrog AI Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

10.7M

Sector

Technology

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.21

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFRG
BNGO
Founded
2017
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
12.5M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
BFRG
BNGO
Price
$0.58
$1.21
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
116.3K
137.4K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
25.88
94.50
EPS
N/A
N/A
Revenue
$116,670.00
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
79.49
26.26
52 Week Low
$0.43
$1.00
52 Week High
$2.04
$5.50

Technical Indicators

Market Signals
Indicator
BFRG
BNGO
Relative Strength Index (RSI) 47.81 58.08
Support Level $0.51 $1.10
Resistance Level $0.69 $1.31
Average True Range (ATR) 0.04 0.06
MACD 0.00 0.01
Stochastic Oscillator 44.62 71.06

Price Performance

Historical Comparison
BFRG
BNGO

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: